Keppra and Petechiae - from FDA reports


Summary

Petechiae is found among people who take Keppra, especially for people who are female, 60+ old , have been taking the drug for 1 - 6 months, also take medication Lasix, and have Glioblastoma. This review analyzes which people have Petechiae with Keppra. It is created by eHealthMe based on reports of 37,835 people who have side effects when taking Keppra from FDA , and is updated regularly.

What to expect?

If you take Keppra and have Petechiae, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Keppra and have Petechiae

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Aug, 21, 2017

37,835 people reported to have side effects when taking Keppra.
Among them, 70 people (0.19%) have Petechiae


Number of reports submitted per year:

Could Keppra cause Petechiae?

Time on Keppra when people have Petechiae *:

  • < 1 month: 11.11 %
  • 1 - 6 months: 66.67 %
  • 6 - 12 months: 11.11 %
  • 1 - 2 years: 7.41 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 3.7 %
  • 10+ years: 0.0 %

Gender of people who have Petechiae when taking Keppra *:

  • female: 65.71 %
  • male: 34.29 %

Age of people who have Petechiae when taking Keppra *:

  • 0-1: 1.56 %
  • 2-9: 7.81 %
  • 10-19: 4.69 %
  • 20-29: 14.06 %
  • 30-39: 18.75 %
  • 40-49: 4.69 %
  • 50-59: 14.06 %
  • 60+: 29.69 %

Top conditions involved for these people *:

  • Glioblastoma (12 people, 17.14%)
  • Nuclear Magnetic Resonance Imaging Brain (7 people, 10.00%)
  • Convulsion (6 people, 8.57%)
  • Partial Seizures (5 people, 7.14%)
  • Complex Partial Seizures (5 people, 7.14%)

Top co-used drugs for these people *:

  • Lasix (12 people, 17.14%)
  • Valium (11 people, 15.71%)
  • Decadron (11 people, 15.71%)
  • Norvasc (9 people, 12.86%)
  • Nexium (9 people, 12.86%)

Top other side effects for these people *:

  • Thrombocytopenia (16 people, 22.86%)
  • Rashes (15 people, 21.43%)
  • Pancytopenia (14 people, 20.00%)
  • Nosebleed (14 people, 20.00%)
  • Head Injury (14 people, 20.00%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Petechiae when taking Keppra?

Expand the study to include all drugs with the same ingredients

Petechiae and drugs with ingredients of levetiracetam.

Expand the study to include reports from both FDA and eHealthMe

Petechiae and Keppra from FDA and eHealthMe reports

Keppra

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. (latest outcomes from Keppra 40,429 users)

Petechiae

Petechiae (a small red or purple spot caused by bleeding into the skin) has been reported by people with high blood pressure, rheumatoid arthritis, idiopathic thrombocytopenic purpura, atrial fibrillation/flutter, depression (latest reports from 8,773 Petechiae patients).

Browse all side effects of Keppra

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Petechiae

Petechiae

Could your condition cause Petechiae

Petechiae

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Keppra and have Petechiae.

Can you answer these questions?

More questions for: Keppra, Petechiae

You may be interested in these reviews

More reviews for: Keppra, Petechiae